Development of a new high-throughput test for cystic fibrosis mutation screening

被引:0
|
作者
Balashov, S. [1 ]
Mordechai, E. [2 ]
Adelson, M. E. [2 ]
机构
[1] Res & Dev, Med Diagnost Labs, Hamilton, NJ USA
[2] Med Diagnost Labs, Hamilton, NJ USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2007年 / 9卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:659 / 659
页数:1
相关论文
共 50 条
  • [23] High-Throughput Screening
    Wildey, Mary Jo
    Haunso, Anders
    Tudor, Matthew
    Webb, Maria
    Connick, Jonathan H.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 149 - 195
  • [25] High-throughput screening
    Rogers, MV
    DRUG DISCOVERY TODAY, 1997, 2 (07) : 306 - 306
  • [26] High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel
    Tomati, Valeria
    Pesce, Emanuela
    Caci, Emanuela
    Sondo, Elvira
    Scudieri, Paolo
    Marini, Monica
    Amato, Felice
    Castaldo, Giuseppe
    Ravazzolo, Roberto
    Galietta, Luis J. V.
    Pedemonte, Nicoletta
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (04) : 1203 - 1217
  • [27] Potential therapeutic agents for cystic fibrosis identified by high throughput screening
    Liang, L.
    Schwiebert, E.
    Guggino, W. B.
    PEDIATRIC PULMONOLOGY, 2007, : 295 - 295
  • [28] A new high-throughput serum-based precolonoscopy screening test for colorectal cancer
    Ritchie, S.
    Heath, D.
    Krenitsky, K.
    Ardie, K.
    Sylwestrowicz, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 30 - 30
  • [29] High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening
    Ma, TH
    Vetrivel, L
    Yang, H
    Pedemonte, N
    Zegarra-Moran, O
    Galietta, LJV
    Verkman, AS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 37235 - 37241
  • [30] Accelerating Discovery and Development with Advances in High-Throughput Screening
    Challener, Cynthia A.
    Pharmaceutical Technology, 2024, 48 (11) : 12 - 16